Incidence of adverse drug reactions with commonly prescribed drugs in tertiary care teaching hospital in India

International Journal of Research in Pharmaceutical Sciences

Volumn 3, Issue 1, 2012, Pages 79-83

  Ahmad, Akram ^a   Parimalakrishnan, S ^a   Mohanta, G P ^a   Manna, P K ^a   Manavalan, R ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

ADR; Casualty assessment; Incidence; Naranjo score; Pharmacovigilance

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; ALGORITHM; ARTICLE; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; DIZZINESS; DRUG SURVEILLANCE PROGRAM; ECONOMIC ASPECT; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; INCIDENCE; INDIA; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; OBSERVATIONAL STUDY; PUBLIC HEALTH PROBLEM; RASH; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SKIN DISEASE; TEACHING HOSPITAL; TERTIARY HEALTH CARE; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 84857704139     PISSN: None     EISSN: 09757538     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA, 1997; 277: 307-311.
2. Beijer HJM and de Blaey CJ. Hospitalizations caused by adverse drug reactions: A metaanalysis of observational studies. Pharm World Sci, 2002; 24: 46-54.
3. Central Drugs Standard Control Organisation, Government of India, Home page, Available from http://cdsco.nic.in/html/Drugsbanned.html(accessed on 20 july 2011)
4. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerised surveillance of adverse drug events in hospital patients. JAMA 1991; 266:2847-2851.
5. Classen DC, Pestonik SL, Scott Evans R, Lloyd JF and Burke JP. Adverse drug events in hospitalized patients. JAMA, 1997; 277: 301-306.
6. Emma C Davies, Christophe F Green, David R Mottram and Munir Pirmohamed. Adverse drug reaction in Hospital: A Narrative Review. Current Drug Safety, 2007; 2: 79-87.
7. Green CF, Mottram DR, Rowe P and Brown AM. Set-ting up a hospital based local adverse drug reaction monitoring scheme. Hosp Pharm, 1997; 4: 75-78.
8. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006; 54: 226-233.
9. Lazarou J, Pomeranz BH and Corey PN. Incidence of adverse drug reaction in hospital patients. A meta-analysis of prospective studies. JAMA, 1998; 279:1200-1205.
10. Murphy BM, Frigo LC. Development, implementation and results of a successful multidisciplinary adverse drug reactions reporting program in a University teaching hospital. Hosp Pharm 1993; 28:1199-1204.
11. Ogilvie R and Ruedy J. Adverse drug reactions during hospitalization. Can Med Ass J, 1967; 97: 1450-1457.
12. Parthasarathi G, Nyfort-Hansen K and Milap C Nahata. A textbook of clinical pharmacy practice. Orient Longman Pvt. Ltd., Hyderabad. 2007, P 84-85.
13. Prosser TR, Kamysz PL. Multidisciplinary adverse drug reaction surveillance programme. Am J Hosp Pharm 1990; 47: 1334-1339.
14. Ramesh M, Pandit J and Parthasarathi G. Adverse drug reactions in a south Indian hospital - their severity and cost involved. Pharmacoepidemiol Drug Saf, 2003; 12: 687-692.
15. Suh DC, Woodall BS, Shin SK, Hermes-de-Santis ER. Clinical and economic impact of adverse drug reactions in hospitalised patients. Ann Pharmacother 2000; 34: 1373-1379.
16. th Ed, 2008, Jaypee Brothers Medical Publishers Pvt. Ltd., New Delhi. P 77.
17. Vargas E, Terleira A, Hernando F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med, 2003; 31(3): 694-698.
18. th Ed, 2008, Churchill Livingstone Elsevier, USA, P 51.
19. WHO. International drug monitoring-the role of the national centres, Tech Rep Ser WHO. 1972; P 498.